AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12475511
Drug: Functional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional treatment (displaced position accepted, not rereduced)
Trial: 10424315
Drug: Propranolol 160
RxNorm normalized name: propranolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 160 mg once daily
Trial: 29747269
Drug: Low-dose CEE
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CEE + progesterone
Trial: 29747269
Drug: Standard-dose CEE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose CEE + progesterone
Trial: 29747269
Drug: Standard-dose CEE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose CEE + dydrogesterone
Trial: 29747269
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (Low-dose CEE + progesterone, Standard-dose CEE + progesterone, Standard-dose CEE + dydrogesterone
Trial: 22354104
Drug: Triple-injection US-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-injection US-guided AXB
Trial: 22354104
Drug: Quadruple-injection US-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple-injection US-guided AXB
Trial: 22354104
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (double, triple, quadruple injections)
Trial: 12370684
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia (IVA) - continuous infusion of 30 mg of morphine and 180 mg ketorolac in 250 mL of normal saline at 5 mL/h.
Trial: 10757583
Drug: Remifentanil 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 4 microg kg(‐1) + Propofol 2.5 mg kg(‐1)
Trial: 1549538
Drug: Ofloxacin 600
RxNorm normalized name: ofloxacin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 600 mg
Trial: 2853934
Drug: Flutamide 250
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 250 mg three times daily
Trial: 22914876
Drug: Prior brace
RxNorm normalized name: Brace Relief
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prior brace treatment for over 1 year (Group A)
Trial: 22914876
Drug: No prior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prior treatment (Group B)
Trial: 21420599
Drug: 0.25 mg/mL
RxNorm normalized name: thiram 0.25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/mL diclofenac sodium
Trial: 21420599
Drug: 0.25 mg/mL
RxNorm normalized name: thiram 0.25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/mL combined diclofenac sodium and nuclear rotation
Trial: 17534812
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution (Group 1)
Trial: 19864903
Drug: NaF solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaF solution (positive control, 1,000 mg/kg F, pH 4.5)
Trial: 15369510
Drug: G group
RxNorm normalized name: DIMETHICONE 10.2 mg in 1 mL TOPICAL SPRAY [KVG Group, Inc. FXP Cracked Heel Formula]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G group (genotypic group)
Trial: 11443179
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg micronized estradiol‐17beta orally, twice daily for 14 days
Trial: 7820215
Drug: Thyroid hormone
RxNorm normalized name: Thyroid hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid hormone replacement therapy
Trial: 26205747
Drug: Non-surgical periodontal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical periodontal treatment (NSPT) in the form of scaling and root planing (SRP)
Trial: 26205747
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no periodontal therapy)
Trial: 23585306
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of ibuprofen (400 mg ibuprofen/20 mL suspension)
Trial: 21672969
Drug: Infliximab 5
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 5 mg/kg i.v./6 weeks for 8 years
Trial: 19682233
Drug: Pre-hospital high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-hospital high-dose tirofiban
Trial: 19682233
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no high-dose tirofiban/placebo)
Trial: 14736293
Drug: Conceptual difficulty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conceptual difficulty in potential insight solution
Trial: 3504454
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel (0.5 mg) placed intracervically
Trial: 20535638
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg once daily (Group 1)
Trial: 2090208
Drug: One single
RxNorm normalized name: Risperidone Single-Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One single dose of 4 g piperacillin 30 minutes before surgery
Trial: 2090208
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of 4 g piperacillin (30 minutes before surgery, and 6 & 12 hours after surgery)
Trial: 31897428
Drug: SYNT001 (FcRn-blocking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SYNT001 (FcRn-blocking monoclonal antibody)
Trial: 28327503
Drug: Nitrate-rich beetroot
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrate-rich beetroot juice (140 mL; 800 mg nitrate/day)
Trial: 26083948
Drug: Aspirin desensitization
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin desensitization (AD) with increasing doses of aspirin (60, 125, 325, and 625 mg) followed by 625 mg twice daily for 6 months
Trial: 26366802
Drug: Aspirin desensitization
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin desensitization (AD)
Trial: 23462833
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus Atorvastatin 10 mg
Trial: 11996956
Drug: Fenofibrate (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibrate (200 mg)
Trial: 20183663
Drug: Solution‐Focused Thinking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution‐Focused Thinking
Trial: 16395269
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron sucrose 100 mg
Trial: 15312371
Drug: Postoperative TACE
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative TACE and thymosin alpha(1) (T(alpha1)) treatment (Group A)
Trial: 9260798
Drug: Alendronate (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (40 mg/day)
Trial: 9260798
Drug: Aspirin (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1, 300 mg/day)
Trial: 29016880
Drug: Intranasal hydrocodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal hydrocodone ER
Trial: 29016880
Drug: Intranasal hydrocodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal hydrocodone powder
Trial: 29016880
Drug: Intranasal treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal treatments
Trial: 29016880
Drug: Intact oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact oral hydrocodone ER
Trial: 24535134
Drug: Laquinimod 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laquinimod 0.6 mg once-daily
Trial: 25458646
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin plus glycoprotein IIb/IIIa inhibitors
Trial: 10838648
Drug: PATCH model
RxNorm normalized name: Model AA 2012 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PATCH model intervention (n=310)
Trial: 23116485
Drug: Ketoconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (400 mg)
Trial: 3108064
Drug: Indomethacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (200 mg) administered 15 and 2 hours before testing
Trial: 25209524
Drug: Nicotine Replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine Replacement Therapy (NRT) provided at discharge
Trial: 24708748
Drug: Drug-negative patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-negative patients (84% opioids, 76% stimulants, 62% alcohol, 33% marijuana)
Trial: 24708748
Drug: Drug-positive patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-positive patients
Trial: 21169896
Drug: Olanzapine (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5-10 mg daily)
Trial: 21169896
Drug: Sertraline (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50-100 mg daily)
Trial: 17035872
Drug: iopamidol-370 (370
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iopamidol-370 (370 mgI/mL)
Trial: 17035872
Drug: iodixanol-320 (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iodixanol-320 (320 mgI/mL)
Trial: 23918282
Drug: Balloon treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon treatment
Trial: 10696316
Drug: Injection into
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection into the intra‐Tenon's space (subconjunctival space) without making a conjunctival incision (116 eyes)
Trial: 8540712
Drug: Cefodizime 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime 0.5 g
Trial: 2074253
Drug: Cefodizime 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime 1.0 g
Trial: 2074253
Drug: Cefodizime 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime 2.0 g
Trial: 8540712
Drug: Cefodizime 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime 3.0 g
Trial: 1571381
Drug: Cefodizime (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime (all doses)
Trial: 6794746
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin injection (20 U of regular insulin) into an empty peritoneal cavity
Trial: 6794746
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin injection (20 U of regular insulin) followed by 2 litres of 4.5% dextrose dialysate
Trial: 6794746
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin injection (20 U of regular insulin) followed by 20 ml of saline
Trial: 11717214
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol anesthesia (n = 6)
Trial: 9159421
Drug: Assessment of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assessment of gynaecological disorders including measurement of hormone concentrations, cervical cytology, and pelvic ultrasound scan.
Trial: 29641671
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with tramadol hydrochloride injection
Trial: 12818266
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg daily for up to 12 months
Trial: 12818266
Drug: Esomeprazole 40,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40, 20, or 10 mg daily for up to 6 months
Trial: 8992517
Drug: Flupentixol (exact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupentixol (exact dosage and duration not specified)
Trial: 6362698
Drug: Flunitrazepam (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (2.0 mg)
Trial: 30804065
Drug: Genetically predicted
RxNorm normalized name: Burosumab (genetical recombination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetically predicted serum calcium concentrations (increase of 0.5 mg/dL)
Trial: 18591543
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant interleukin-2 (rIL-2) maintenance immunotherapy for 90 days, consisting of 14-day cycles followed by 3-day higher doses.
Trial: 7640501
Drug: Fungus Lipid‐reducing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fungus Lipid‐reducing Capsule (FLC) treated group
Trial: 2860283
Drug: Temazepam 20
RxNorm normalized name: temazepam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam 20 mg in uncoated tablet
Trial: 18426844
Drug: Praneem polyherbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praneem polyherbal vaginal tablet
Trial: 11716075
Drug: 1% chlorhexidine/methylcellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% chlorhexidine/methylcellulose gel (group C)
Trial: 11716075
Drug: Positive control
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive control (no medication)
Trial: 2291751
Drug: Sodium naproxen
RxNorm normalized name: Naproxen Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium naproxen 550 mg every 12 h
Trial: 2291751
Drug: Sodium diclofenac
RxNorm normalized name: Diclofenac Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium diclofenac 100 mg every 12 h
Trial: 31101682
Drug: best standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: best standard therapy (BST)
Trial: 28383414
Drug: Lidocaine-prilocaine cream
RxNorm normalized name: lidocaine / prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine-prilocaine cream (5% lidocaine and 25 mg/g prilocaine, 5g applied preoperatively)
Trial: 19056445
Drug: Telephone recall
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone recall system managed by pediatricians from asthma clinic with vaccine administered in the same clinic (group 3)
Trial: 11408210
Drug: Isoniazid (INH)
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid (INH) 5 mg/kg daily and rifampin (RIF) 10 mg/kg daily
Trial: 11408210
Drug: Isoniazid (INH)
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid (INH) 5 mg/kg daily plus 10 mg of rifalazil once weekly
Trial: 9495409
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg intrathecal morphine plus 75 mg i.m. diclofenac every 8 h
Trial: 9495409
Drug: 0.05 mg
RxNorm normalized name: biotin 0.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg intrathecal morphine plus i.m. diclofenac on demand
Trial: 9495409
Drug: 0.025 mg
RxNorm normalized name: lisuride 0.025 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg intrathecal morphine plus i.m. diclofenac on demand
Trial: 3053587
Drug: Carbohydrate feeding
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate feeding (1 g/kg at 10 min, then 0.6 g/kg every 30 min)
Trial: 31902925
Drug: DT algorithm
RxNorm normalized name: L-DT
DrugBank: Telbivudine (DB01265)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: DT algorithm for initial dose settings of VCM
Trial: 31902925
Drug: Conventional dose-setting
RxNorm normalized name: DRESSING,WET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dose-setting methods
Trial: 28287490
Drug: Vitamin B12-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin B12-containing multiple micronutrient supplement
Trial: 21984924
Drug: gp140 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gp140 vaccine (100 µg in 3 ml of Carbopol 974P based gel)
Trial: 21984924
Drug: Placebo solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo solution in Carbopol gel
Trial: 18224343
Drug: Mizoribine combination
RxNorm normalized name: Mizoribine
DrugBank: Mizoribine (DB12617)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mizoribine combination therapy
Trial: 20674417
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg metoclopramide
Trial: 14633536
Drug: 0.02 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.02 mg/kg droperidol
Trial: 14633536
Drug: 0.13 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.13 mg/kg ondansetron
Trial: 20395895
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL saline
Trial: 14633536
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg metoclopramide
Trial: 1485367
Drug: 300 or
RxNorm normalized name: Xodol 5/300 Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 or 600 mg of racemic ibuprofen (chronic dosing)
Trial: 20461028
Drug: Duloxetine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (60 mg once daily for the first 7 weeks, increased to 120 mg for those with <30% pain reduction at week 7)
Trial: 12752317
Drug: 0.75 mg
RxNorm normalized name: propinox 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg bid everolimus
Trial: 12752317
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg bid everolimus
Trial: 7408407
Drug: Oral bretylium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bretylium tosylate (5 mg/kg)
Trial: 7408407
Drug: Intravenous bretylium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bretylium tosylate (5 mg/kg)
Trial: 27296626
Drug: 15-week oral
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 15-week oral language programme delivered by trained teaching assistants
Trial: 21816640
Drug: Low-dose ATN-224
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ATN-224 (30 mg daily)
Trial: 21816640
Drug: High-dose ATN-224
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ATN-224 (300 mg daily)
Trial: 21640687
Drug: Bedtime cilnidipine
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime cilnidipine (10-20 mg/day)
Trial: 12657911
Drug: Racemic reboxetine
RxNorm normalized name: REBOXETINE
DrugBank: Reboxetine (DB00234)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic reboxetine (6-month monotherapy)
Trial: 4050068
Drug: Aspirin-dipyridamole (ASA-D)
RxNorm normalized name: aspirin / dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin-dipyridamole (ASA-D)
Trial: 4050068
Drug: Anticoagulation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulation with coumadine preparations (AC)
Trial: 31880109
Drug: Critical care
RxNorm normalized name: Adult critical care formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Critical care ultrasound oriented treatment
Trial: 24591296
Drug: Nasal douche
RxNorm normalized name: Alkalol Nasal Douche Cup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal douche containing 9 mg of high molecular weight sodium hyaluronate plus saline solution
Trial: 24591296
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution alone
Trial: 22137609
Drug: Integrated pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Integrated pharmaceutical care programme (IPCP)
Trial: 6395920
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (Subgroup O)
Trial: 6395920
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + Tamoxifen (Subgroup N)
Trial: 6395920
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + Tamoxifen + Norethisterone (Subgroup NN)
Trial: 6395920
Drug: Chemotherapy (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Group I)
Trial: 17211866
Drug: IA carboplatin
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IA carboplatin with intravenous etoposide and cyclophosphamide
Trial: 17211866
Drug: IA methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IA methotrexate with intravenous etoposide and cyclophosphamide
Trial: 12171809
Drug: Nortriptyline, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline, 75 mg/d for 6 weeks
Trial: 7758327
Drug: Histamine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine (0.1 mg/ml) administered via subcutaneous injections or by scratching at the site of patch tests